Both adipsin and properdin genes were reported among 50 genes useful for leukemia class prediction, allowing the distinguishing of acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML) patients [15]. This evidence concerns the gene CFD and acute lymphoblastic leukemia.